查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954510

日本家用诊断检测市场规模、份额、趋势及预测（按检测类型、形式、通路和地区划分，2026-2034年）

Japan Home Diagnostic Testing Market Size, Share, Trends and Forecast by Test Type, Form, Distribution Channel, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 5-7个工作天内

价格
简介目录

预计到 2025 年，日本家庭诊断测试市场规模将达到 3.5556 亿美元，到 2034 年将达到 9.5629 亿美元，2026 年至 2034 年的复合年增长率为 11.62%。

受人口老化加剧导致慢性病发病率上升以及消费者对频繁健康监测需求不断增长的推动，日本家用诊断检测市场持续稳定扩张。意识提升以及对便利家庭检测方案的偏好进一步强化了这项需求。政府推行的预防医学和数位健康融合政策也促进了市场成长。携带式诊断设备的科技进步、零售药局网路的扩张以及电子商务渗透率的提高，提升了产品在全国范围内的可及性，从而推动了日本家用诊断检测市场份额的成长。

主要结论与见解：

  • 按测试类型划分：到 2025 年，血糖值监测仪将以 34% 的市场份额引领市场，这主要得益于需要定期进行血糖值管理的糖尿病患者人数不断增加，以及老年人群体对持续血糖监测系统日益增长的需求，他们正在寻求便捷的疾病管理解决方案。
  • 按形式划分：到 2025 年，试纸将以 29% 的市场份额引领市场，这得益于其成本效益、易于用于自我测试以及在全国零售药局和药房的广泛供应。
  • 按分销管道划分：到 2025 年，零售药局将成为最大的细分市场，占市场份额的 40%。这主要得益于消费者对药剂师指导的信任、广泛的门市网路提供全面的产品种类，以及能够即时获得医疗需求产品的便利性。
  • 从地区来看，到 2025 年，关东地区将以 36% 的市占率领先。这主要归功于大东京地区人口稠密、医疗基础设施先进、消费者购买力强，以及大型医疗机构和数位健康Start-Ups的存在。
  • 主要参与者：日本家用诊断测试市场呈现竞争适中的格局，成熟的跨国诊断公司与国内製造商并存，提供涵盖各种测试类别和价格点的多样化产品系列。

日本家庭诊断检测市场持续受益于国家对医疗创新的大力投入以及科技与日常健康管理的无缝整合。厚生劳动省第八次医疗策略计画（2024-2029）强调资讯通信技术（ICT）数位化在医疗保健领域的应用，为家庭诊断解决方案创造了有利环境。消费者日益重视隐私，尤其是在敏感疾病的健康检查方面，这进一步推动了对无需就医即可获得准确结果的家庭检测替代方案的需求。零售通路的拓展、预防性检测保险覆盖范围的扩大以及政府大力推广早期检测，也增强了市场前景。随着製造商推出更多便捷可靠的疾病特异性检测套组，预计将实现市场多元化和加速增长，从而吸引寻求独立生活的老年人和希望更快、更便捷地获取健康信息的年轻人。

日本家用诊断检测市场的发展趋势：

人工智慧 (AI) 与数位健康技术的融合

随着人工智慧（AI）技术融入诊断设备和健康平台，日本的家用诊断市场正经历重大变革。配备机器学习（ML）演算法的智慧诊断设备能够实现持续的健康监测和潜在疾病的早期检测。这些技巧有助于及时干预，同时减少患者频繁就医的次数。 2025年1月，Monitor公司与DoctorNet合作，在日本推出了人工智慧肺癌诊断工具“MONCAD CTLN”，这体现了日本致力于透过人工智慧提升诊断能力的决心。

远端医疗和远端患者监护的兴起

远端医疗服务的扩展与日本各地的居家诊断检测解决方案形成了协同效应。数位健康平台正加强与居家检测套组的整合，从而实现患者与医疗服务提供者之间无缝的数据共用。这一趋势反映了消费者对便利医疗服务日益增长的需求，并有助于缓解医疗机构的拥挤状况。 2024年7月，亚马逊在日本推出了药房服务，与多家当地药房合作，将处方药直接送到客户家中，并透过数位应用程式提供药剂师咨询服务。

即时检测 (POC) 解决方案的采用率不断提高

随着消费者和医疗机构对在传统检查室之外获得即时诊断结果的需求日益增长，即时检测（POC​​）解决方案正受到广泛关注。根据IMARC集团预测，日本即时诊断市场规模预计在2024年达到17亿美元。能够使用单一试剂盒检测多种病原体的携带式多重检测设备正变得越来越精密。这些进步有助于当日制定治疗方案，并提高慢性病管理的效率。

2026-2034年市场展望：

携带式诊断设备的持续技术创新、远端医疗的日益普及以及政府对数位健康计画的支持将推动市场扩张。人口老化将维持对血糖监测和慢性病管理解决方案的需求，而年轻一代健康意识的提高将使消费群体更加多元化。预计2025年市场规模将达到3.5556亿美元，到2034年将达到9.5629亿美元，2026年至2034年的复合年增长率（CAGR）为11.62%。零售药局的现代化和电子商务通路的拓展将提高都市区地区的产品供应量。

1. 日本的家庭诊断测试市场规模有多大？

2. 日本家庭诊断检测市场的预期成长率是多少？

3. 在日本家庭诊断测试市场中，哪种类型的测试占了最大的份额？

4.推动市场成长的关键因素是什么？

5. 日本家庭诊断检测市场面临的主要挑战是什么？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章：日本家用诊断检测市场概况

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章：日本家用诊断检测市场：现状

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本家庭诊断检测市场－依检测类型细分

  • 血糖值监测仪
  • 妊娠测试
  • 排卵预测检测套组
  • HIV检测套组
  • 胆固醇检测套装
  • 传染病检查试剂盒
  • 药物滥用检测套组
  • 其他的

第七章：日本家用诊断测试市场－按类型细分

  • 磁带
  • 中游
  • 装置
  • 条
  • 检查
  • 数位监控
  • 沾卡

8. 日本家用诊断测试市场－依销售管道划分

  • 零售药房
  • 药局
  • 大卖场和超级市场
  • 网路药房

第九章：日本家庭诊断检测市场（按地区划分）

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十章：日本家庭诊断检测市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十一章主要企业概况

第十二章：日本家用诊断检测市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十三章附录

简介目录
Product Code: SR112026A36397

The Japan home diagnostic testing market size was valued at USD 355.56 Million in 2025 and is projected to reach USD 956.29 Million by 2034, growing at a compound annual growth rate of 11.62% from 2026-2034.

The Japan home diagnostic testing market is experiencing robust expansion driven by the nation's rapidly aging population, which has led to increased prevalence of chronic conditions requiring frequent monitoring. Rising health awareness among consumers, coupled with preferences for convenient at-home testing solutions, continues to strengthen demand. Government initiatives promoting preventive healthcare and digital health integration further support market momentum. Technological advancements in portable diagnostic devices, combined with expanding retail pharmacy networks and growing e-commerce penetration, are enhancing product accessibility across the country, thereby bolstering Japan home diagnostic testing market share.

KEY TAKEAWAYS AND INSIGHTS :

  • By Test Type: Glucose monitoring devices dominate the market with a share of 34% in 2025, driven by Japan's rising diabetic population requiring regular blood sugar monitoring and the growing adoption of continuous glucose monitoring systems among elderly consumers seeking convenient disease management solutions.
  • By Form: Strips lead the market with a share of 29% in 2025, owing to their cost-effectiveness, ease of use for self-testing applications, and widespread availability across retail pharmacies and drug stores throughout Japan.
  • By Distribution Channel: Retail pharmacies represent the largest segment with a market share of 40% in 2025, supported by consumer trust in pharmacist guidance, extensive store networks offering comprehensive product assortments, and the convenience of immediate product availability for healthcare needs.
  • By Region: Kanto Region prevails the market with a share of 36% in 2025, attributable to its dense population concentration in metropolitan Tokyo, advanced healthcare infrastructure, high consumer spending power, and presence of major healthcare facilities and digital health startups.
  • Key Players: The Japan home diagnostic testing market exhibits a moderately competitive landscape, characterized by the presence of established multinational diagnostic corporations alongside domestic manufacturers offering diverse product portfolios across various testing categories and price segments.

The Japan home diagnostic testing market continues to benefit from the nation's commitment to healthcare innovations and the seamless integration of technology into daily health management routines. The MHLW's 8th National Medical Strategic Plan covering 2024-2029 emphasizes Information and Communications Technology (ICT) and digitalization in healthcare, creating favorable conditions for at-home diagnostic solutions. Consumer preference for privacy in health screening, particularly for sensitive conditions, further accelerates the demand for home-based testing alternatives that provide accurate results without clinical visits. Expanding retail availability, greater insurance support for preventive testing, and proactive government promotion of early detection also strengthen market prospects. As manufacturers introduce more user-friendly, reliable, and disease-specific test kits, the market is expected to diversify and accelerate, appealing to both older adults seeking independence and younger users looking for faster, more accessible health insights.

JAPAN HOME DIAGNOSTIC TESTING MARKET TRENDS:

Integration of Artificial Intelligence (AI) and Digital Health Technologies

The Japan home diagnostic testing market is witnessing significant transformation through AI integration into diagnostic devices and health platforms. Smart diagnostic equipment, featuring machine learning (ML) algorithms, enables continuous health monitoring and early detection of potential conditions. These technologies allow timely interventions while reducing dependence on frequent clinical visits. In January 2025, Monitor Corporation launched its AI lung cancer diagnosis tool, MONCAD CTLN, in Japan through a partnership with Doctor-NET, demonstrating the nation's commitment to advancing AI-powered diagnostic capabilities.

Rise of Telemedicine and Remote Patient Monitoring

The expansion of telemedicine services is creating synergies with home diagnostic testing solutions across Japan. Digital health platforms increasingly integrate with at-home testing kits, enabling seamless data sharing between patients and healthcare providers. This trend reflects growing consumer demand for convenient healthcare access and reduces burden on overcrowded healthcare facilities. In July 2024, Amazon introduced its Pharmacy service in Japan, partnering with various local drugstores to deliver prescription medicines directly to homes while enabling pharmacist consultations through digital applications.

Growing Adoption of Point-of-Care (POC) Testing Solutions

POC testing solutions are gaining substantial traction as consumers and healthcare providers seek immediate diagnostic results outside traditional laboratory settings. As per IMARC Group, the Japan POC diagnostics market size reached USD 1.7 Billion in 2024. Portable multiplex testing devices capable of detecting multiple pathogens in single cartridges are becoming increasingly sophisticated. These advancements support same-visit treatment decisions and enhance chronic disease management efficiency.

MARKET OUTLOOK 2026-2034:

Market expansion will be driven by continued technological innovation in portable diagnostic devices, expanding telemedicine adoption, and government support for digital health initiatives. The aging demographic will sustain demand for glucose monitoring and chronic disease management solutions, while growing health consciousness among younger population will diversify the consumer base. The market generated a revenue of USD 355.56 Million in 2025 and is projected to reach a revenue of USD 956.29 Million by 2034, growing at a compound annual growth rate of 11.62% from 2026-2034. Retail pharmacy modernization and e-commerce channel expansion will enhance product accessibility across urban and rural regions alike.

JAPAN HOME DIAGNOSTIC TESTING MARKET REPORT SEGMENTATION:

Test Type Insights:

  • Glucose Monitoring Devices
  • Pregnancy Test
  • Ovulation Predictor Test Kits
  • HIV Test Kits
  • Cholesterol Detection Kits
  • Infection Testing Kits
  • Drug of Abuse Test Kits
  • Others
  • Glucose monitoring devices dominate with a market share of 34% of the total Japan home diagnostic testing market in 2025.
  • Glucose monitoring devices hold prominence, as Japan's diabetes burden continues to escalate. In 2024, Japan had the 10th largest population of individuals with diabetes worldwide, totaling 10.8 Million. The elderly demographic demonstrates heightened susceptibility to type 2 diabetes and related metabolic conditions. Government reimbursement policies supporting diabetes management device accessibility further strengthen market penetration.
  • Self-monitoring blood glucose devices have become essential tools for daily disease management, enabling patients to track glucose fluctuations and adjust treatment regimens accordingly. This proactive approach helps prevent serious complications, including cardiovascular diseases and kidney disorders. The segment benefits from continuous technological innovations, enhancing device accuracy and user convenience. The integration of digital health applications with glucose monitors enables seamless data sharing with healthcare providers, facilitating personalized treatment adjustments and improving overall patient outcomes in chronic disease management.

Form Insights:

  • Cassettes
  • Midstream
  • Instruments
  • Strips
  • Test
  • Digital Monitoring
  • Dip Cards
  • Strips lead with a share of 29% of the total Japan home diagnostic testing market in 2025.
  • Strips represent the most accessible and cost-effective format for home diagnostic testing applications. Their simple operation requires minimal technical knowledge, making them suitable for elderly consumers and first-time users seeking reliable self-testing solutions. Blood sample collection using strips provides accurate results comparable to laboratory testing while offering the convenience of immediate readings at home. The format's versatility extends across multiple testing categories, including glucose monitoring, cholesterol detection, and infection screening applications.
  • Manufacturing advancements have significantly improved strip sensitivity and accuracy, building consumer confidence in home testing reliability. The format's affordability compared to electronic instruments supports regular testing frequency among chronic disease patients requiring daily monitoring. Retail pharmacies and drug stores maintain comprehensive strip inventories across major brands, ensuring consistent product availability. The established distribution infrastructure combined with competitive pricing strategies positions strips as the preferred format for budget-conscious consumers prioritizing testing accessibility over advanced digital features.

Distribution Channel Insights:

  • Retail Pharmacies
  • Drug Stores
  • Hypermarket and Supermarkets
  • Online Pharmacies
  • Retail pharmacies exhibit a clear dominance with a 40% share of the total Japan home diagnostic testing market in 2025.
  • Retail pharmacies serve as primary healthcare access points throughout Japan, offering consumers professional pharmacist consultation alongside diagnostic product purchases. As per IMARC Group, the Japan pharmacy retail market size reached USD 114.26 Billion in 2024. These establishments provide personalized guidance on product selection, proper testing procedures, and result interpretation, creating value-added shopping experiences that build consumer loyalty. Chain pharmacy dominance ensures standardized service quality and comprehensive product assortments across locations.
  • The channel benefits from established consumer trust in pharmacist expertise and healthcare-related purchasing environments. Immediate product availability eliminates waiting periods associated with online ordering, appealing to consumers requiring urgent diagnostic solutions. Strategic pharmacy locations in residential neighborhoods and commercial districts maximize accessibility for diverse demographic segments. Retail pharmacies increasingly integrate digital services, including prescription management and telemedicine consultations, positioning themselves as comprehensive health management hubs that complement home diagnostic testing product offerings.

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region represents the leading region with a 36% share of the total Japan home diagnostic testing market in 2025.
  • The Kanto Region leads the Japan home diagnostic testing market due to its large, urbanized population, advanced healthcare infrastructure, and strong digital adoption. Tokyo is a large urban city with approximately 37.1 Million inhabitants in 2024. Consumers in Tokyo and surrounding prefectures actively embrace convenient at-home testing solutions to save time and manage health proactively. High awareness about preventive care and broad access to pharmacies, clinics, and online platforms enable rapid market penetration and frequent product upgrades.
  • The region also benefits from the strong presence of technology companies and diagnostic manufacturers that introduce innovative, app-connected self-testing kits tailored to urban lifestyles. Widespread use of smartphones, telehealth platforms, and digital health records supports seamless integration of home diagnostic tools. Additionally, higher disposable incomes and busy work schedules create sustained demand for reliable, fast, and easy-to-use testing options, reinforcing Kanto's position as the most influential and early-adopting market in Japan.

MARKET DYNAMICS:

GROWTH DRIVERS:

  • Why is the Japan Home Diagnostic Testing Market Growing?
  • Rapidly Aging Population and Escalating Chronic Disease Burden
  • Japan's demographic transformation represents a fundamental driver propelling the home diagnostic testing market forward. The nation possesses one of the world's oldest populations, with individuals aged 65 and over comprising 29.3% of total residents as of September 2024. This substantial elderly cohort demonstrates elevated susceptibility to chronic conditions, including diabetes, cardiovascular diseases, and metabolic disorders requiring continuous monitoring. Home diagnostic devices enable convenient disease management without frequent clinical visits, particularly valuable for mobility-limited seniors. Home diagnostic tools provide a convenient, accessible, and non-invasive alternative that enables seniors to track vital health parameters from the comfort of their homes. This shift not only empowers individuals to take greater control of their health but also reduces pressure on overburdened hospitals and clinics, allowing medical professionals to focus on more severe cases.
  • Government Initiatives Supporting Digital Health and Home Healthcare
  • Japanese government policies actively promote home-based healthcare and digital health integration, creating favorable regulatory conditions for market participants. These initiatives encourage telemedicine adoption and remote patient monitoring capabilities that complement home diagnostic testing solutions. As per IMARC Group, the Japan telemedicine market size reached USD 5.2 Billion in 2024. Regulatory pathways have also become more supportive, simplifying approvals for innovative home testing devices and ensuring they meet safety standards. Initiatives encouraging collaborations between medical device manufacturers, tech companies, and healthcare providers further stimulate product innovation tailored to Japan's demographic needs. By reducing regulatory friction, improving digital accessibility, and promoting self-care, the government is effectively shifting health management from clinics to homes, making home diagnostic testing a central part of Japan's modern healthcare strategy.
  • Growing need for nursing care
  • The rising need for nursing care in Japan is strongly driving the home diagnostic testing market, as more individuals, particularly seniors, require continuous monitoring of chronic conditions without relying solely on in-person medical support. In fiscal 2023, in Japan, the overall number of nursing care recipients grew to 5,666,500, marking a 1.3% rise, while the total for preventive care recipients increased by 59,900 (5.1%) to reach 1,244,600. With the country facing a growing shortage of professional caregivers and nurses, families increasingly turn to home-based diagnostic tools to simplify daily health management. These devices allow routine checks for blood glucose, blood pressure, heart rhythm, and other vital indicators, reducing the burden on nursing staff while empowering patients to manage their conditions independently. Home diagnostic solutions also help caregivers track health status more efficiently, enabling early detection of complications and timely medical intervention. For elderly individuals living alone or in assisted environments, self-testing devices enhance safety and autonomy while minimizing frequent clinic visits.

MARKET RESTRAINTS:

  • What Challenges the Japan Home Diagnostic Testing Market is Facing?
  • Regulatory Complexity and Lengthy Approval Processes
  • Japan's stringent medical device regulations create substantial barriers for market entry and product innovations. Complex certification requirements extend approval timelines, delaying introduction of advanced diagnostic technologies. Manufacturers face significant compliance costs navigating regulatory pathways, particularly for novel AI-integrated devices requiring extensive clinical validation.
  • High Device Costs Limiting Consumer Accessibility
  • Premium pricing of advanced home diagnostic devices restricts market penetration among price-sensitive consumer segments. Sophisticated continuous glucose monitoring systems and connected health devices remain financially inaccessible for many households despite clinical benefits. Limited insurance coverage for certain diagnostic categories creates out-of-pocket burden that suppresses demand growth.
  • Data Privacy and Security Concerns
  • Data privacy and security concerns are slowing the growth of the market in Japan by reducing consumer confidence in sharing sensitive health information through digital platforms. Fears of data leaks, misuse of personal medical records, and inadequate protection measures make users hesitant to adopt app-connected or cloud-based test kits. These concerns also pressure companies to invest heavily in compliance, cybersecurity, and transparent data-handling practices, increasing operational complexity.

COMPETITIVE LANDSCAPE:

  • The Japan home diagnostic testing market exhibits moderate competitive intensity, characterized by the presence of established multinational medical device corporations alongside domestic manufacturers. Global players leverage advanced research capabilities, extensive distribution networks, and brand recognition to maintain market positions across premium product categories. Domestic companies compete through localized product development, competitive pricing strategies, and established relationships with healthcare providers and retail channels. Strategic partnerships between technology firms and diagnostic manufacturers are accelerating innovations in connected health solutions. Market participants are increasingly investing in AI integration, digital platform development, and user experience enhancement to differentiate offerings. Distribution channel expansion, particularly through e-commerce and pharmacy partnerships, represents a key competitive focus area.
  • KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the Japan home diagnostic testing market?

2. What is the projected growth rate of the Japan home diagnostic testing market?

3. Which test type held the largest Japan home diagnostic testing market share?

4. What are the key factors driving market growth?

5. What are the major challenges facing the Japan home diagnostic testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Home Diagnostic Testing Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Home Diagnostic Testing Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Home Diagnostic Testing Market - Breakup by Test Type

  • 6.1 Glucose Monitoring Devices
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Pregnancy Test
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Ovulation Predictor Test Kits
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 HIV Test Kits
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Cholesterol Detection Kits
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Forecast (2026-2034)
  • 6.6 Infection Testing Kits
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2020-2025)
    • 6.6.3 Market Forecast (2026-2034)
  • 6.7 Drug of Abuse Test Kits
    • 6.7.1 Overview
    • 6.7.2 Historical and Current Market Trends (2020-2025)
    • 6.7.3 Market Forecast (2026-2034)
  • 6.8 Others
    • 6.8.1 Historical and Current Market Trends (2020-2025)
    • 6.8.2 Market Forecast (2026-2034)

7 Japan Home Diagnostic Testing Market - Breakup by Form

  • 7.1 Cassettes
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Midstream
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Instruments
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Strips
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Test
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)
  • 7.6 Digital Monitoring
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2020-2025)
    • 7.6.3 Market Forecast (2026-2034)
  • 7.7 Dip Cards
    • 7.7.1 Overview
    • 7.7.2 Historical and Current Market Trends (2020-2025)
    • 7.7.3 Market Forecast (2026-2034)

8 Japan Home Diagnostic Testing Market - Breakup by Distribution Channel

  • 8.1 Retail Pharmacies
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Drug Stores
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Hypermarket and Supermarkets
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Online Pharmacies
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Forecast (2026-2034)

9 Japan Home Diagnostic Testing Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Breakup by Test Type
    • 9.1.4 Market Breakup by Form
    • 9.1.5 Market Breakup by Distribution Channel
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2026-2034)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Breakup by Test Type
    • 9.2.4 Market Breakup by Form
    • 9.2.5 Market Breakup by Distribution Channel
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2026-2034)
  • 9.3 Central/ Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Breakup by Test Type
    • 9.3.4 Market Breakup by Form
    • 9.3.5 Market Breakup by Distribution Channel
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2026-2034)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Breakup by Test Type
    • 9.4.4 Market Breakup by Form
    • 9.4.5 Market Breakup by Distribution Channel
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2026-2034)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Breakup by Test Type
    • 9.5.4 Market Breakup by Form
    • 9.5.5 Market Breakup by Distribution Channel
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2026-2034)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Breakup by Test Type
    • 9.6.4 Market Breakup by Form
    • 9.6.5 Market Breakup by Distribution Channel
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2026-2034)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2020-2025)
    • 9.7.3 Market Breakup by Test Type
    • 9.7.4 Market Breakup by Form
    • 9.7.5 Market Breakup by Distribution Channel
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2026-2034)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2020-2025)
    • 9.8.3 Market Breakup by Test Type
    • 9.8.4 Market Breakup by Form
    • 9.8.5 Market Breakup by Distribution Channel
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2026-2034)

10 Japan Home Diagnostic Testing Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Products Offered
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Products Offered
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Products Offered
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Products Offered
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Products Offered
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Home Diagnostic Testing Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix